Penumbra, Inc. to Present at Upcoming Investor Conferences
Get Alerts PEN Hot Sheet
Join SI Premium – FREE
Event: | |
Date: | |
Time: |
Event: | Jefferies Global Healthcare Conference |
Date: | |
Time: |
Event: | Truist Securities MedTech Conference |
Date: | |
Time: |
Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcasts will be available on the company's website for at least two weeks following each event.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.
Investor Relations
Penumbra, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-upcoming-investor-conferences-302442997.html
SOURCE Penumbra, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HTX Research Examines U.S. AI Equities: Technology Remains Early, While Capital Expenditure and Valuations Have Entered the Late Cycle
- Crypto News: Hyperliquid, TRUMP Memecoin, and MemeToro Shape the 2026 Altcoin Market
- Pump.Fun Price Prediction: Memecoin Traders Buy MemeToro and PUMP For Upcoming Crypto Bull Run
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
William Blair, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share